BOLT.TA TLV
BioLight Life Sciences Ltd.
1W: +4.6%
1M: -6.5%
3M: -25.6%
YTD: -18.1%
1Y: -46.4%
3Y: -57.5%
5Y: -57.0%
₪290.10 ($0.95)
-6.30 (-2.13%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$544K
-348.4% ▼
Operating Income
-$15M
-100.2% ▼
Net Income
-$12M
-64.2% ▼
EPS (Diluted)
$-1.98
-29.4% ▼
EBITDA
-$15M
-89.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3K | $63K | $118K | $219K | $0 |
| YoY Growth | -90.3% | +2000.0% | +87.3% | +85.6% | -100.0% |
| Cost of Revenue | $532K | $588K | $0 | $595K | $544K |
| Gross Profit | $3K | $63K | $118K | $219K | -$544K |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D Expenses | $4M | $4M | $5M | $4M | $5M |
| SG&A Expenses | $3M | $3M | $6M | $3M | $10M |
| Operating Expenses | $535K | $9M | $27M | $8M | $15M |
| Operating Income | -$532K | -$9M | -$27M | -$8M | -$15M |
| Operating Margin | -17733.3% | -13804.8% | -22516.1% | -3468.9% | — |
| Interest Expense | $74K | $80K | $77K | $94K | $92K |
| Income Before Tax | -$2M | -$9M | -$27M | -$8M | -$17M |
| Tax Expense | -$2M | $0 | $0 | $0 | $0 |
| Net Income | $382K | -$8M | -$26M | -$7M | -$12M |
| Net Margin | 12733.3% | -12455.6% | -22050.8% | -3261.2% | — |
| EPS (Diluted) | $0.08 | $-1.71 | $-5.60 | $-1.53 | $-1.98 |
| EBITDA | -$1M | -$8M | -$11M | -$8M | -$15M |
| Shares Outstanding | 5M | 5M | 5M | 5M | 6M |